What is Newborn Foundation?
The Newborn Foundation operates at the intersection of medical technology and public health advocacy, specifically targeting the reduction of infant mortality. Through its flagship BORN Project, the organization utilizes mobile pulse oximetry to facilitate critical point-of-care screening for newborns. This innovative approach addresses the urgent need for early detection of congenital heart defects and other health complications during the first days of life. By integrating advanced diagnostic tools into standard clinical workflows, the foundation has established itself as a critical player in the global effort to improve health outcomes for vulnerable infants, effectively bridging the gap between high-tech medical solutions and accessible neonatal care.
How much funding has Newborn Foundation raised?
Newborn Foundation has raised a total of $16K across 1 funding round:
Debt
$16K
Debt (2021): $16K with participation from PPP
Key Investors in Newborn Foundation
PPP
Public-Private Partnership
What's next for Newborn Foundation?
With the recent influx of capital, the Newborn Foundation is poised to accelerate its strategic roadmap, focusing on the widespread adoption of its screening technologies. The organization is expected to prioritize the expansion of its BORN Project, potentially entering new geographic markets where neonatal mortality rates remain a significant public health challenge. Furthermore, the foundation will likely invest in research and development to enhance its existing diagnostic platforms, ensuring that its technological solutions remain at the forefront of pediatric medicine. As it moves through this Series A/B growth stage, the foundation's ability to demonstrate measurable improvements in infant health outcomes will be paramount to securing future investment and sustaining its long-term mission.
See full Newborn Foundation company page
